Causes of rare forms eye disorders in young patients discovered

Article

Through the use of next-generation DNA sequencing techniques, researchers from the University of Leeds have discovered the causes of rare forms of inherited eye disorders in paediatric patients.

Through the use of next-generation DNA sequencing techniques, researchers from the University of Leeds have discovered the causes of rare forms of inherited eye disorders in paediatric patients.

In collaborative work with colleagues at Flinders University in Adelaide, Australia, Dr Manir Ali and team (University of Leeds, UK) studied the DNA from three unrelated families that all had members with a history of poor vision from birth linked to the eye's lens and cornea. It was found that all the family members with impaired vision had defects in an antioxidant protein, peroxidasin, which assists in the development of lens and cornea.

The technique used to make the discovery, next-generation DNA sequencing, allows genes to be read quickly and enables users to spot errors that cause inherited disorders. It is hoped that this discovery will help in the identification of families at risk of conceiving children with severe vision impairment, so that appropriate counselling can be given. Additionally, further worked is planned to use the same technique in screening every eye gene simultaneously to assist in diagnosis and treatment time.

Full details of the study were published in the American Journal of Human Genetics and more information may be found on the University's website: www.leeds.ac.uk

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.